IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccine

समान संसाधन

• Single DermaVir Immunization: Dose-Dependent Expansion of Precursor/Memory T Cells against All HIV Antigens in HIV-1 Infected Individuals
  द्वारा: Lisziewicz, Julianna, और अन्य
  प्रकाशित: (2012)
• Safety, Tolerability and Immunogenicity of Repeated Doses of DermaVir, a Candidate Therapeutic HIV Vaccine, in HIV Infected Patients Receiving Combination Antiretroviral Therapy. Results of the ACTG 5176 Trial
  द्वारा: Rodriguez, Benigno, और अन्य
  प्रकाशित: (2013)
• Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8(+) memory cell pool
  द्वारा: Melchionda, Fraia, और अन्य
  प्रकाशित: (2005)
• Utilizing IL-12, IL-15 and IL-7 as Mucosal Vaccine Adjuvants
  द्वारा: Stevceva, Liljana, और अन्य
  प्रकाशित: (2006)
• Whole Tumor Cell Vaccine Adjuvants: Comparing IL-12 to IL-2 and IL-15
  द्वारा: Abdolkarim Sheikhi, और अन्य
  प्रकाशित: (2016-09-01)